Clinical Trials Logo

Clinical Trial Summary

The Effect of Mouthwash Containing Green Tea With Aloe Vera and Chlorhexidine Mouthwash on Oral Malodour Among a Group of Egyptian Children: Randomized Clinical Trial


Clinical Trial Description

1. Diagnosis:

1. Diagnostic chart (Appendix A) will be filled with personal, medical and dental history. DMF and def caries index (decayed, missing, and filled teeth).

2. The intra oral and extra oral examinations will be made using masks, gloves, cap, goggles, gauze, medical tray, dental mirror and WHO ( World Health Organization ) probe. All materials will be packaged in sterilizations wraps and autoclave, following the required bio safety standards

2. Intervention:

• The participants included will be allocated into two groups by drawing of sealed and opaque envelopes containing the codes "A" and "B".

Experimental Group:( intervention ) Green tea with Aloe- Vera

1. Preparation of green tea with aloe - Vera will occur under aseptic condition by pharmacist (Sargolzaie et al, 2015).

2. Collection of saliva samples (pre-rinse) will be obtained from children who fulfilled the inclusion criteria.

3. Distinguish odors using the Smell identification test (Doty et al. 1984). Breath was scored as described by Rosenberg at rest (open mouth without breathing) and when the patients counted from 1 to 11 (Rosenberg, 1996). A 0-5 score was given (Green man et al. 2004).

4. Subjects will be instructed to wash and retain the respective mouth rinse in the mouth for 40 Seconds before expectorating it.

5. 15 min after a rinse , Breath was scored as described by Rosenberg at rest (open mouth without breathing) and when the patients counted from 1 to 11 (Rosenberg, 1996). A 0-5 score was given (Green man et al. 2004). (masking effect)

6. Patients will not allow consuming any diet or drinking orally for following 90 min.

7. Again after 90 min, the saliva samples will be taken and inoculated on blood agar plates to determine the colony count (Velmurugan et al, 2013) and

8. Patients with confirmed oral malodor rinsed mouthwash during 7 days (15 ml, 2x/day for 1 min.)

9. After 7 days Breath was scored as described by Rosenberg at rest (open mouth without breathing) and when the patients counted from 1 to 11 (Rosenberg, 1996). A 0-5 score was given (Green man et al. 2004). (therapeutic effect).

Comparative Group:

Commercial Chlorhexidine 0.2%

1. Collection of saliva samples (pre-rinse) will be obtained from children who fulfilled the inclusion criteria.

2. Distinguish odors using the Smell identification test (Doty et al. 1984). Breath was scored as described by Rosenberg at rest (open mouth without breathing) and when the patients counted from 1 to 11 (Rosenberg, 1996). A 0-5 score was given (Green man et al. 2004).

3. Subjects will be instructed to wash and retain the respective mouth rinse in the mouth for 40 Seconds before expectorating it.

4. 15 min after a rinse , Breath was scored as described by Rosenberg at rest (open mouth without breathing) and when the patients counted from 1 to 11 (Rosenberg, 1996). A 0-5 score was given (Green man et al. 2004). (masking effect)

5. Patients will not allow consuming any diet or drinking orally for following 90 mins.

6. Again after 90 min, the saliva samples will be taken and inoculated on blood agar plates to determine the colony count (Velmurugan et al, 2013) .

7. Patients with confirmed oral malodor rinsed mouthwash during 7 days (15 ml, 2x/day for 1 min.)

8. After 7 days Breath was scored as described by Rosenberg at rest (open mouth without breathing) and when the patients counted from 1 to 11 (Rosenberg, 1996). A 0-5 score was given (Green man et al. 2004). (therapeutic effect). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03115892
Study type Interventional
Source Cairo University
Contact
Status Enrolling by invitation
Phase Phase 1/Phase 2
Start date April 1, 2017
Completion date December 1, 2017

See also
  Status Clinical Trial Phase
Completed NCT04279106 - Effect of Single Rinsing With Three Different Types of Mouthwash on VSC Levels in Morning Breath N/A
Completed NCT04914208 - Effect of Wearing Face Masks on Salivary Parameters and Halitosis N/A
Completed NCT05413382 - Effect of an Investigational Lozenge (Biofresh® 4plus) Versus Placebo Control on Oral Malodor (Intra-Oral Halitosis) N/A
Completed NCT05524948 - A Clinical Study to Examine the Effects of an Experimental Toothpaste Compared to a Regular Fluoride Toothpaste on Breath Odor in a Population With Gingivitis N/A
Completed NCT02689297 - Three Different Oral Hygiene Regimes on Three Volatile Sulfur Compounds Phase 4
Completed NCT02113137 - Oral Hygiene Procedures on Reduction of Oral Malodor Phase 4
Completed NCT01046812 - Halitosis Devised Questionnaire Evaluating a New Treatment N/A
Withdrawn NCT02665780 - Assessing the Effect of Periodontal Debridement, Tongue Cleaning and Mouth Rinsing for the Treatment of Oral Malodour N/A
Completed NCT01948349 - Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient N/A
Recruiting NCT02007993 - Photodynamic Therapy in Adolescents Halitosis N/A
Completed NCT01269957 - Halitosis and Mouth Breathing in Children N/A
Completed NCT04632004 - Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health N/A
Completed NCT04998617 - Effects of Curcumin-containing Toothpaste on Dental Biofilm and Associated Oral Halitosis N/A
Completed NCT01139073 - A New Portable Monitor for Measuring Odorous Compounds in Oral, Exhaled and Nasal Air N/A
Not yet recruiting NCT00875927 - Effects of Breezy Candy on Halitosis Phase 1/Phase 2
Completed NCT03196648 - Randomized Trial of a Gum Health Formulation N/A
Recruiting NCT03346460 - Effect of Photodymamic Therapy With Urucum and LED in the Reduction of Halitosis Phase 2
Completed NCT03468595 - Clinical Evaluation of Some Local Antimicrobial Agents' Adjunctive Effects On Periodontal Parameters and Halitosis N/A
Completed NCT02628938 - Effect of Miswak and Miswak Extract on Oral Malodor Phase 2
Completed NCT02794766 - Inulin and S. Salivarius Reduce Halitosis Phase 2